SCHEMBL19797362

SCHEMBL19797362

Cc1nc(P(=O)(c2ccccc2)c2ccc(N3c4ccccc4C(C)(C)c4ccccc43)c(C)n2)ccc1N1c2ccccc2C(C)(C)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 4/20 0.36
▸ HTT P42858 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ RECQL P46063 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ PGR P06401 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ CASP1 P29466 1/20 0.30
▸ CASP7 P55210 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797375 0.97 NPSR1 (0.36) NPSR1HTTLMNAKMT2AMEN1
SCHEMBL19797364 0.92 NPSR1 (0.33) NPSR1HTTLMNAKMT2AMEN1
SCHEMBL19797371 0.82 HTT (0.34) NPSR1HTTLMNAKMT2AMEN1
SCHEMBL19797365 0.79 KMT2A (0.34) NPSR1HTTLMNAKMT2AMEN1
SCHEMBL19797352 0.77 EGLN1 (0.33) HTTLMNAKMT2AMEN1MAPT
SCHEMBL19367098 0.76 KMT2A (0.38) NPSR1HTTLMNAKMT2AMEN1
SCHEMBL19797360 0.74 EGLN1 (0.33) HTTLMNAKMT2AMEN1MAPT
SCHEMBL18396907 0.74 ALDH1A1 (0.42) NPSR1HTTLMNAKMT2AMEN1
SCHEMBL13231589 0.74 LMNA (0.39) HTTLMNAKMT2AMEN1MAPT
SCHEMBL19797383 0.73 ALDH1A1 (0.38) NPSR1HTTLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-20 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CYP1B1 NPSR1 4005/4885HTT 2064/4885LMNA 2798/4885
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices CRY1, CRY2, PER2 NPSR1 2792/4885HTT 3907/4885LMNA 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback